Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective January 19, 2021, the Board of Directors (the "Board") of MusclePharm Corporation (the "Company") appointed Michael Heller to serve as a director until the Company's 2021 annual meeting of stockholders or his earlier death, resignation or removal. The Company expects Mr. Heller to serve on the Board's Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

Mr. Heller will be compensated for his service as a director in accordance with the Company's non-employee director compensation policy. The Company plans to enter into an indemnification agreement with Mr. Heller, which will provide him with indemnification in connection with his service as a member of the Board.

© Edgar Online, source Glimpses